SeaStar Medical Holding Corporation (ICU) - Total Assets
Based on the latest financial reports, SeaStar Medical Holding Corporation (ICU) holds total assets worth $15.53 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ICU net asset value for net asset value and shareholders' equity analysis.
SeaStar Medical Holding Corporation - Total Assets Trend (2020–2024)
This chart illustrates how SeaStar Medical Holding Corporation's total assets have evolved over time, based on quarterly financial data.
SeaStar Medical Holding Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
SeaStar Medical Holding Corporation's total assets of $15.53 Million consist of 80.9% current assets and 19.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 39.1% |
| Accounts Receivable | $112.00K | 2.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how SeaStar Medical Holding Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SeaStar Medical Holding Corporation (ICU) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SeaStar Medical Holding Corporation's current assets represent 80.9% of total assets in 2024, a decrease from 99.9% in 2020.
- Cash Position: Cash and equivalents constituted 39.1% of total assets in 2024, down from 96.5% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 2.4% of total assets.
SeaStar Medical Holding Corporation Competitors by Total Assets
Key competitors of SeaStar Medical Holding Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
SeaStar Medical Holding Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.66 | 0.54 | 0.15 |
| Quick Ratio | 3.64 | 0.54 | 0.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $10.81 Million | $-3.02 Million | $-211.06K |
SeaStar Medical Holding Corporation - Advanced Valuation Insights
This section examines the relationship between SeaStar Medical Holding Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.80 |
| Latest Market Cap to Assets Ratio | 1.96 |
| Asset Growth Rate (YoY) | 32.6% |
| Total Assets | $4.66 Million |
| Market Capitalization | $9.12 Million USD |
Valuation Analysis
Above Book Valuation: The market values SeaStar Medical Holding Corporation's assets above their book value (1.96x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: SeaStar Medical Holding Corporation's assets grew by 32.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SeaStar Medical Holding Corporation (2020–2024)
The table below shows the annual total assets of SeaStar Medical Holding Corporation from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.66 Million | +32.59% |
| 2023-12-31 | $3.51 Million | +15.64% |
| 2022-12-31 | $3.04 Million | +403.81% |
| 2021-12-31 | $603.00K | -79.27% |
| 2020-12-31 | $2.91 Million | -- |
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hy… Read more